| Year |
Citation |
Score |
| 2023 |
Do WL, Wang L, Forgues M, Liu J, Rabibhadana S, Pupacdi B, Zhao Y, Gholian H, Bhudhisawasdi V, Pairojkul C, Sukeepaisarnjaroen W, Pugkhem A, Luvira V, Lertprasertsuke N, Chotirosniramit A, ... ... Budhu A, et al. Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cell Reports. Medicine. 4: 101328. PMID 38118412 DOI: 10.1016/j.xcrm.2023.101328 |
0.337 |
|
| 2023 |
Craig AJ, Silveira MAD, Ma L, Revsine M, Wang L, Heinrich S, Rae Z, Ruchinskas A, Dadkhah K, Do W, Behrens S, Mehrabadi FR, Dominguez DA, Forgues M, Budhu A, et al. Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing. Cell Reports. 42: 113446. PMID 37980571 DOI: 10.1016/j.celrep.2023.113446 |
0.405 |
|
| 2023 |
Pomyen Y, Chaisaingmongkol J, Rabibhadana S, Pupacdi B, Sripan D, Chornkrathok C, Budhu A, Budhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Ungtrakul T, Sricharunrat T, Phornphutkul K, et al. Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Scientific Reports. 13: 11406. PMID 37452065 DOI: 10.1038/s41598-023-38307-2 |
0.404 |
|
| 2021 |
Wang Z, Budhu AS, Shen Y, Wong LL, Hernandez BY, Tiirikainen M, Ma X, Irwin ML, Lu L, Zhao H, Lim JK, Taddei T, Mishra L, Pawlish K, Stroup A, et al. Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study. Jgh Open : An Open Access Journal of Gastroenterology and Hepatology. 5: 1363-1372. PMID 34950780 DOI: 10.1002/jgh3.12682 |
0.312 |
|
| 2021 |
Pomyen Y, Budhu A, Chaisaingmongkol J, Forgues M, Dang H, Ruchirawat M, Mahidol C, Wang XW. Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma. Scientific Reports. 11: 12097. PMID 34103600 DOI: 10.1038/s41598-021-91560-1 |
0.359 |
|
| 2021 |
Hung MH, Lee JS, Ma C, Diggs LP, Heinrich S, Chang CW, Ma L, Forgues M, Budhu A, Chaisaingmongkol J, Ruchirawat M, Ruppin E, Greten TF, Wang XW. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nature Communications. 12: 1455. PMID 33674593 DOI: 10.1038/s41467-021-21804-1 |
0.329 |
|
| 2020 |
Gu Y, Ji F, Liu N, Zhao Y, Wei X, Hu S, Jia W, Wang XW, Budhu A, Ji J, Zhao B, Roessler S, Zheng X, Ji J. Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 39: 268. PMID 33256802 DOI: 10.1186/s13046-020-01785-7 |
0.331 |
|
| 2020 |
Candia J, Bayarsaikhan E, Tandon M, Budhu A, Forgues M, Tovuu LO, Tudev U, Lack J, Chao A, Chinburen J, Wang XW. The genomic landscape of Mongolian hepatocellular carcinoma. Nature Communications. 11: 4383. PMID 32873799 DOI: 10.1038/S41467-020-18186-1 |
0.4 |
|
| 2020 |
Liu J, Tang W, Budhu A, Forgues M, Hernandez MO, Candia J, Kim Y, Bowman ED, Ambs S, Zhao Y, Tran B, Wu X, Koh C, Surana P, Liang TJ, et al. A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma. Cell. PMID 32526205 DOI: 10.1016/J.Cell.2020.05.038 |
0.434 |
|
| 2020 |
Wang XW, Budhu A, Chaisaingmongkol J, Pomyen Y, Ruchirawat M, Greten TF. Abstract IA40: Race-related liver tumor subtypes are associated with gut microbiome-mediated metabolism Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Ia40 |
0.318 |
|
| 2020 |
Hung MH, Lee JS, Heinrich S, Chan CW, Ma L, Forgues M, Budhu A, Chaisaingmongko J, Ruchirawat M, Ruppin E, Wang XW. Abstract 1687: Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma Tumor Biology. DOI: 10.1158/1538-7445.Am2020-1687 |
0.404 |
|
| 2019 |
Fako V, Martin SP, Pomyen Y, Budhu A, Chaisaingmongkol J, Franck S, Lee JM, Ng IO, Cheung TT, Wei X, Liu N, Ji J, Zhao L, Liu Z, Jia HL, et al. Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization. International Journal of Biological Sciences. 15: 2654-2663. PMID 31754337 DOI: 10.7150/Ijbs.39534 |
0.418 |
|
| 2019 |
Kwon SM, Budhu A, Woo HG, Chaisaingmongkol J, Dang H, Forgues M, Harris CC, Zhang G, Auslander N, Ruppin E, Mahidol C, Ruchirawat M, Wang XW. Functional Genomic Complexity Defines Intratumor Heterogeneity and Tumor Aggressiveness in Liver Cancer. Scientific Reports. 9: 16930. PMID 31729408 DOI: 10.1038/S41598-019-52578-8 |
0.345 |
|
| 2019 |
Haznadar M, Diehl CM, Parker AL, Krausz KW, Bowman ED, Rabibhadana S, Forgues M, Bhudhisawasdi V, Gonzalez FJ, Mahidol C, Budhu A, Wang XW, Ruchirawat M, Harris CC. Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31358519 DOI: 10.1158/1055-9965.Epi-19-0453 |
0.317 |
|
| 2019 |
Dang H, Pomyen Y, Martin SP, Dominguez DA, Yim SY, Lee JS, Budhu A, Shah AP, Bodzin AS, Wang XW. NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma. Scientific Reports. 9: 3369. PMID 30833661 DOI: 10.1038/S41598-019-39727-9 |
0.463 |
|
| 2019 |
Satriano L, Lewinska M, Rourke CO, Oliveira DV, Bhatt DK, Taranta A, Herr M, Straub B, Conner EA, Budhu A, Pomyen Y, Ma T, Gerhart-Hines Z, Stjernegaard CS, Matter M, et al. THU-491-The role of alanine glyoxylate aminotransferase in hepatocellular carcinoma Journal of Hepatology. 70. DOI: 10.1016/S0618-8278(19)30738-8 |
0.428 |
|
| 2018 |
Zheng H, Pomyen Y, Hernandez MO, Li C, Livak F, Tang W, Dang H, Greten TF, Davis JL, Zhao Y, Mehta M, Levin Y, Shetty J, Tran B, Budhu A, et al. Single cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 29315726 DOI: 10.1002/Hep.29778 |
0.406 |
|
| 2017 |
Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, et al. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Cell. PMID 28648284 DOI: 10.1016/J.Ccell.2017.05.009 |
0.485 |
|
| 2017 |
Zheng H, Pomyen Y, Hernandez M, Li C, Livak F, Greten T, Budhu A, Wang X. Abstract 936: Single cell analysis reveals cancer stem cell heterogeneities in hepatocellular carcinoma Cancer Research. 77: 936-936. DOI: 10.1158/1538-7445.Am2017-936 |
0.427 |
|
| 2016 |
Fako V, Yu Z, Henrich CJ, Ransom T, Budhu AS, Wang XW. Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide. International Journal of Biological Sciences. 12: 768-75. PMID 27313491 DOI: 10.7150/Ijbs.14718 |
0.466 |
|
| 2016 |
Takai A, Fako V, Dang H, Forgues M, Yu Z, Budhu A, Wang XW. Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma. Scientific Reports. 6: 21174. PMID 26880118 DOI: 10.1038/Srep21174 |
0.451 |
|
| 2015 |
Ji J, Eggert T, Budhu A, Forgues M, Takai A, Dang H, Ye Q, Lee JS, Kim JH, Greten TF, Wang XW. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 25833323 DOI: 10.1002/Hep.27822 |
0.507 |
|
| 2015 |
Zhao X, Parpart S, Takai A, Roessler S, Budhu A, Yu Z, Blank M, Zhang YE, Jia HL, Ye QH, Qin LX, Tang ZY, Thorgeirsson SS, Wang XW. Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma. Oncogene. PMID 25597408 DOI: 10.1038/Onc.2014.438 |
0.502 |
|
| 2015 |
Roessler S, Lin G, Forgues M, Budhu A, Hoover S, Simpson RM, Wu X, He P, Qin LX, Tang ZY, Ye QH, Wang XW. Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma. International Journal of Biological Sciences. 11: 88-98. PMID 25552933 DOI: 10.7150/Ijbs.10583 |
0.405 |
|
| 2015 |
Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Forgues M, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, et al. Abstract LB-173: The Thailand initiative in genomics and expression research for liver cancer (TIGER-LC): Defining novel subtypes of hepatocellular carcinoma and cholangiocarcinoma Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-173 |
0.486 |
|
| 2014 |
Roessler S, Budhu A, Wang XW. Deciphering cancer heterogeneity: the biological space. Frontiers in Cell and Developmental Biology. 2: 12. PMID 25364720 DOI: 10.3389/Fcell.2014.00012 |
0.403 |
|
| 2014 |
Budhu A, Terunuma A, Zhang G, Hussain SP, Ambs S, Wang XW. Metabolic profiles are principally different between cancers of the liver, pancreas and breast. International Journal of Biological Sciences. 10: 966-72. PMID 25210494 DOI: 10.7150/Ijbs.9810 |
0.326 |
|
| 2013 |
Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin LX, Ye QH, Jia HL, Fan J, Sun HC, Tang ZY, Wang XW. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology. 144: 1066-1075.e1. PMID 23376425 DOI: 10.1053/J.Gastro.2013.01.054 |
0.436 |
|
| 2012 |
Budhu A, Wang XW. Transforming the microenvironment: a trick of the metastatic cancer cell. Cancer Cell. 22: 279-80. PMID 22975368 DOI: 10.1016/J.Ccr.2012.08.018 |
0.336 |
|
| 2012 |
Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, Qin LX, Yamashita T, Woo HG, Kim YJ, Kaneko S, et al. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md.). 56: 1792-803. PMID 22707408 DOI: 10.1002/hep.25890 |
0.302 |
|
| 2012 |
Budhu A, Wang XW. At the cancer steering wheel: defining key genomic drivers of liver cancer with next generation sequencing. Journal of Hepatology. 56: 1412-4. PMID 22286003 DOI: 10.1016/J.Jhep.2011.12.024 |
0.457 |
|
| 2012 |
Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, Tang ZY, He P, Hunter KW, Thorgeirsson SS, Meltzer PS, et al. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology. 142: 957-966.e12. PMID 22202459 DOI: 10.1053/J.Gastro.2011.12.039 |
0.461 |
|
| 2012 |
Zhao X, Roessler S, Budhu A, Yu Z, Jia H, Ye Q, Qin L, Tang Z, Wang XW. Abstract LB-408: An integrative genomic approach uncovers oncogenic roles of YY1-signaling in hepatocellular carcinoma with stem cell-like traits Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-408 |
0.389 |
|
| 2011 |
Budhu A, Wang XW. Power play: scoring our goals for liver cancer with better GWAS study design. Journal of Hepatology. 54: 823-4. PMID 21167853 DOI: 10.1016/J.Jhep.2010.10.035 |
0.439 |
|
| 2011 |
Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, Tang ZY, Sun Z, Harris CC, Thorgeirsson SS. Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology. 140: 1063-70. PMID 21094160 DOI: 10.1053/j.gastro.2010.11.034 |
0.304 |
|
| 2010 |
Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, Wang XW. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Research. 70: 10202-12. PMID 21159642 DOI: 10.1158/0008-5472.CAN-10-2607 |
0.312 |
|
| 2010 |
Budhu A, Ji J, Wang XW. The clinical potential of microRNAs Journal of Hematology & Oncology. 3: 37-37. PMID 20925959 DOI: 10.1186/1756-8722-3-37 |
0.313 |
|
| 2010 |
Ji J, Zhao L, Budhu A, Forgues M, Jia H, Qin L, Ye Q, Yu J, Shi X, Tang Z, Wang XW. Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinoma Journal of Hepatology. 52: 690-697. PMID 20338660 DOI: 10.1016/J.Jhep.2009.12.025 |
0.445 |
|
| 2010 |
Roessler SK, Jia H, Budhu AS, Qin L, Ye Q, Thorgeirsson S, Tang Z, Wang XW. Abstract 4818: Validation and clinical utility of a human hepatocellular carcinoma metastasis signature as prognostic classifier Cancer Research. 70: 4818-4818. DOI: 10.1158/1538-7445.Am10-4818 |
0.489 |
|
| 2010 |
Budhu AS, Yu Z, Forgues M, Tang ZY, Croce CM, Wang XW. Abstract 3003: Immune cell-related microRNA-155 is associated with human liver cirrhosis and hepatocellular carcinoma Cancer Research. 70: 3003-3003. DOI: 10.1158/1538-7445.Am10-3003 |
0.4 |
|
| 2010 |
Woo HG, Wang XW, Budhu A, Tang Z, Sun Z, Harris CC, Thorgeirsson SS. Abstract 1983: TP53 mutations in hepatocellular carcinoma: Association with survival and stem cell-like gene expression traits Cancer Research. 70: 1983-1983. DOI: 10.1158/1538-7445.Am10-1983 |
0.421 |
|
| 2009 |
Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, Qin LX, Yang W, Wang HY, Tang ZY, Croce CM, et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology (Baltimore, Md.). 50: 472-80. PMID 19585654 DOI: 10.1002/Hep.22989 |
0.456 |
|
| 2009 |
Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology. 136: 1012-24. PMID 19150350 DOI: 10.1053/J.Gastro.2008.12.004 |
0.481 |
|
| 2008 |
Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Research. 68: 1451-61. PMID 18316609 DOI: 10.1158/0008-5472.Can-07-6013 |
0.416 |
|
| 2008 |
Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology (Baltimore, Md.). 47: 897-907. PMID 18176954 DOI: 10.1002/Hep.22160 |
0.407 |
|
| 2008 |
Roessler S, Budhu A, Wang XW. Future of molecular profiling of human hepatocellular carcinoma. Future Oncology (London, England). 3: 429-39. PMID 17661718 DOI: 10.2217/14796694.3.4.429 |
0.389 |
|
| 2007 |
Yamashita T, Budhu A, Forgues M, Wang XW. Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular Carcinoma Cancer Research. 67: 10831-10839. PMID 18006828 DOI: 10.1158/0008-5472.Can-07-0908 |
0.41 |
|
| 2007 |
Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, Shen F, Tang ZY, Wang XW. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1133-9. PMID 17317821 DOI: 10.1158/1078-0432.CCR-06-1025 |
0.383 |
|
| 2006 |
Budhu A, Wang XW. The role of cytokines in hepatocellular carcinoma. Journal of Leukocyte Biology. 80: 1197-213. PMID 16946019 DOI: 10.1189/jlb.0506297 |
0.375 |
|
| 2006 |
Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 10: 99-111. PMID 16904609 DOI: 10.1016/J.Ccr.2006.06.016 |
0.373 |
|
| 2005 |
Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW. The molecular signature of metastases of human hepatocellular carcinoma. Oncology. 69: 23-7. PMID 16210873 DOI: 10.1159/000086628 |
0.487 |
|
| 2004 |
Kim JW, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, Hofseth LJ, Kaul R, Wang XW. Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology (Baltimore, Md.). 39: 518-27. PMID 14768006 DOI: 10.1002/Hep.20053 |
0.382 |
|
| 2003 |
Manor D, Shmidt EN, Budhu A, Flesken-Nikitin A, Zgola M, Page R, Nikitin AY, Noy N. Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Research. 63: 4426-33. PMID 12907615 |
0.511 |
|
| 2002 |
Budhu AS, Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Molecular and Cellular Biology. 22: 2632-41. PMID 11909957 DOI: 10.1128/Mcb.22.8.2632-2641.2002 |
0.529 |
|
| 2001 |
Budhu A, Gillilan R, Noy N. Localization of the RAR interaction domain of cellular retinoic acid binding protein-II Journal of Molecular Biology. 305: 939-949. PMID 11162104 DOI: 10.1006/Jmbi.2000.4340 |
0.519 |
|
| 2000 |
Budhu AS, Noy N. On the role of the carboxyl-terminal helix of RXR in the interactions of the receptor with ligand. Biochemistry. 39: 4090-5. PMID 10747799 DOI: 10.1021/Bi992827F |
0.482 |
|
| Show low-probability matches. |